Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Huntington Bancshares enters its October 22 earnings report in an awkward position: the stock is down 11% over the past month to $15.17, yet options traders have turned notably more bullish than usual at exactly the moment the analyst community is pulling targets lower.
The options signal is the sharpest divergence worth watching. The put/call ratio has dropped to 0.70, almost exactly two standard deviations below its 20-day average of 0.86. That is the most call-heavy reading in the past year, with the 52-week low sitting at 0.30. The shift stands out because it has arrived during a month of sustained price weakness, suggesting some investors are positioning for a bounce rather than bracing for further downside into the print.
The lending market tells a quieter story. Short interest is low at about 3% of free float, and it has been drifting lower, down roughly 0.6% on the week and 3.5% over the past month. Availability is effectively unlimited, far above any level that would indicate squeeze pressure. Borrowing costs are just 0.46%, up around 16% on the week but well within the noise at that absolute level. The short-score has been easing steadily, now at 30.7, down from 31.1 ten days ago. None of this suggests an aggressive bear thesis in the lending market.
The Street's direction is more cautious. Consensus remains at buy, with 12 buy-side ratings and a mean target around $19.22, implying roughly 27% upside from here. But every analyst who has moved in the past three weeks has cut their target, not raised it. JP Morgan trimmed to $17.50 from $19.50 last week. UBS lowered to $19 from $22. Keefe, Bruyette and Woods cut to $18 from $19.50 while holding at Market Perform. TD Cowen reinstated this morning with a Buy and an $18 target. The pattern is consistent: bulls are staying constructive on the franchise but marking down their nearer-term expectations. The bear case centres on the NII guidance reduction, NIM still pressured around 3.21% to 3.24%, and slowing loan growth as the bank pulls back from CRE and indirect auto rather than loosen underwriting. The bull case rests on a targeted 17% to 18% ROTCE in 2027, a discounted valuation near 9x 2027 EPS and 0.96x price-to-book, plus expanding footprints in Texas and the Carolinas following the Veritex and Cadence integrations.
On valuation, price-to-book has compressed by about 0.09x over the past 30 days, now at 0.96x, and the P/E has shed about 0.5 turns to 8.9x. Both moves track the stock's decline rather than a fundamental re-rating, but they do leave HBAN trading below book for the first time in a while, which historically attracts value-oriented buyers in regional banks.
FDIC call report data from the Federal Deposit Insurance Corporation shows net loans and leases at Huntington's insured bank charters have risen for nine consecutive quarters, reaching roughly $188 billion as of the second quarter. That streak is the standout fact from the alternative data. The FDIC dataset has not been tested for a measurable lead on Huntington's reported figures, so it is colour rather than signal, but the streak at least confirms that the organic balance sheet has been expanding even as the stock has lagged.
Among peers, the broader weakness is sector-wide but HBAN is the laggard. USB fell 2.75% on the week, FITB dropped about 0.9%, PNC was off 2%, and KEY lost roughly 1.2%. Huntington's own weekly decline of 0.6% is modest by comparison, though the one-month drop of nearly 11% is steeper than most peers managed over the same stretch.
The October 22 earnings report is the obvious near-term focus. The last two prints both saw the stock fall on the day, down 2.5% after Q1 and down 5% after Q2, with the five-day move after Q2 reaching negative 6.5%. What to watch is whether management updates NII guidance and whether the expansion markets in Texas and the Carolinas are generating enough fee revenue growth to offset the margin headwinds that have driven the recent target cuts.
See the live data behind this article on ORTEX.
Open HBAN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
